SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Coherent (COHR) : Anyone else holding?
COHR 154.52-3.0%Nov 7 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Doug who wrote (405)1/19/1998 10:02:00 PM
From: Dan Packer  Read Replies (1) of 788
 
<<Price/Cash flow valuations would make sense if spending for Acquistions/R&D were the norm and Retained earnings were near Nil.>>

Help me out, I don't know what you mean by 'norm'.

My observation was that so long as COHR can make more money than they need for cost type expenses, the business will continue to grow shareholder equity. It will be reflected in share price ultimately.

I'm ignorant about TA. I like their market position, and I like their cash generation.

Dan
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext